Novatek Pharmaceuticals
Phase 2Novatek Pharmaceuticals specializes in developing NP-101—a naturally derived immunotherapy from Nigella Sativa (black seed oil)—targeting cancers and infectious diseases. Clinical trials show enhanced T-cell responses. Learn more.
Founded
2003
Focus
Small Molecules
About
Novatek Pharmaceuticals specializes in developing NP-101—a naturally derived immunotherapy from Nigella Sativa (black seed oil)—targeting cancers and infectious diseases. Clinical trials show enhanced T-cell responses. Learn more.
Company Info
TypePrivate
Founded2003
LocationSalt Lake City, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile